Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 443 shares of the company’s stock, valued at approximately $28,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Massmutual Trust Co. FSB ADV lifted its position in DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $27,000 after buying an additional 500 shares in the last quarter. Mather Group LLC. increased its stake in shares of DocuSign by 4,338.5% in the 2nd quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Brooklyn Investment Group acquired a new position in shares of DocuSign during the 3rd quarter valued at about $33,000. Reston Wealth Management LLC purchased a new stake in shares of DocuSign in the third quarter valued at about $47,000. Finally, nVerses Capital LLC acquired a new stake in DocuSign during the second quarter worth about $48,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have commented on DOCU. Robert W. Baird lifted their target price on DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Citigroup boosted their price objective on shares of DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a report on Friday, September 6th. JPMorgan Chase & Co. increased their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Tuesday. JMP Securities boosted their price target on shares of DocuSign from $84.00 to $108.00 and gave the company a “market outperform” rating in a research note on Friday, November 22nd. Finally, Jefferies Financial Group upped their price objective on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $70.73.
DocuSign Stock Up 0.2 %
Shares of NASDAQ:DOCU opened at $80.45 on Wednesday. The company has a market capitalization of $16.33 billion, a price-to-earnings ratio of 16.97, a price-to-earnings-growth ratio of 8.31 and a beta of 0.92. The company has a 50 day moving average of $72.86 and a two-hundred day moving average of $61.36. DocuSign, Inc. has a 52-week low of $44.34 and a 52-week high of $86.75.
DocuSign (NASDAQ:DOCU – Get Free Report) last released its earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.80 by $0.17. The company had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.09 EPS. On average, equities analysts anticipate that DocuSign, Inc. will post 1.03 earnings per share for the current year.
Insider Transactions at DocuSign
In related news, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the transaction, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at $8,058,993.48. This represents a 7.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $56.56, for a total value of $30,203.04. Following the transaction, the director now directly owns 7,202 shares in the company, valued at $407,345.12. This trade represents a 6.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 69,596 shares of company stock worth $4,441,529. 1.66% of the stock is currently owned by insiders.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- 3 Small Caps With Big Return Potential
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What Do S&P 500 Stocks Tell Investors About the Market?
- Netflix Is On Track To Hit $1,000 By Christmas
- Insider Buying Explained: What Investors Need to Know
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.